| Eosinophils in COPD exacerbations are associated with increased readmissions S Couillard, P Larivée, J Courteau, A Vanasse Chest 151 (2), 366-373, 2017 | 186 | 2017 |
| Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide S Couillard, A Laugerud, M Jabeen, S Ramakrishnan, J Melhorn, T Hinks, ... Thorax 77 (2), 199-202, 2022 | 86 | 2022 |
| Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma S Couillard, R Shrimanker, R Chaudhuri, AH Mansur, LP McGarvey, ... American journal of respiratory and critical care medicine 204 (6), 731-734, 2021 | 51 | 2021 |
| Blood eosinophil depletion with mepolizumab, benralizumab, and prednisolone in eosinophilic asthma AM Moran, S Ramakrishnan, CA Borg, CM Connolly, S Couillard, ... American Journal of Respiratory and Critical Care Medicine 202 (9), 1314-1316, 2020 | 44 | 2020 |
| Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization M Bélanger, S Couillard, J Courteau, P Larivée, TG Poder, N Carrier, ... International Journal of Chronic Obstructive Pulmonary Disease, 3045-3054, 2018 | 37 | 2018 |
| Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE) S Couillard, WIH Do, R Beasley, TSC Hinks, ID Pavord ERJ Open Research 8 (1), 2022 | 29 | 2022 |
| Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the'6W'multidimensional model of care trajectories A Vanasse, J Courteau, M Courteau, M Benigeri, YM Chiu, I Dufour, ... BMC health services research 20, 1-15, 2020 | 29 | 2020 |
| Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: a ‘bomb’(blood eosinophils) meets ‘magnet’(feno) framework S Couillard, ID Pavord, LG Heaney, N Petousi, TSC Hinks Respirology 27 (8), 573-577, 2022 | 23 | 2022 |
| Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths Q Li, P Larivée, J Courteau, S Couillard, TG Poder, N Carrier, M Bélanger, ... International Journal of Chronic Obstructive Pulmonary Disease, 331-341, 2019 | 23 | 2019 |
| Workup of severe asthma S Couillard, DJ Jackson, ME Wechsler, ID Pavord Chest 160 (6), 2019-2029, 2021 | 22 | 2021 |
| Perception of bronchoconstriction following methacholine and eucapnic voluntary hyperpnea challenges in elite athletes S Couillard, V Bougault, J Turmel, LP Boulet Chest 145 (4), 794-802, 2014 | 21 | 2014 |
| Asthma in pregnancy: an update S Couillard, C Connolly, C Borg, I Pavord Obstetric Medicine 14 (3), 135-144, 2021 | 16 | 2021 |
| Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and‐low severe asthma L Khalfaoui, FA Symon, S Couillard, B Hargadon, R Chaudhuri, S Bicknell, ... Allergy 77 (10), 2974-2986, 2022 | 13 | 2022 |
| Predicting one-year mortality after a “first” hospitalization for chronic obstructive pulmonary disease: an eight-variable assessment score tool A Vanasse, J Courteau, S Couillard, MF Beauchesne, P Larivée COPD: Journal of Chronic Obstructive Pulmonary Disease 14 (5), 490-497, 2017 | 13 | 2017 |
| Toward a predict and prevent approach in obstructive airway diseases S Couillard, N Petousi, KS Smigiel, NA Molfino The Journal of Allergy and Clinical Immunology: In Practice 11 (3), 704-712, 2023 | 10 | 2023 |
| Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level … S Couillard, E Steyerberg, R Beasley, I Pavord BMJ open 12 (4), e058215, 2022 | 10 | 2022 |
| Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada TG Poder, N Carrier, M Bélanger, S Couillard, J Courteau, P Larivée, ... International Journal of Chronic Obstructive Pulmonary Disease, 3065-3076, 2018 | 10 | 2018 |
| Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition … M Blaiss, J Oppenheimer, M Corbett, L Bacharier, J Bernstein, T Carr, ... Annals of Allergy, Asthma & Immunology 131 (6), 782-785, 2023 | 8 | 2023 |
| Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing S Couillard, R Shrimanker, S Lemaire-Paquette, GM Hynes, C Borg, ... Thorax 77 (9), 933-938, 2022 | 8 | 2022 |
| Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma S Couillard, ID Pavord Respirology 27 (3), 184-186, 2022 | 7 | 2022 |
Ian PavordUniversity of OxfordVerified email at ndm.ox.ac.uk
